Oncotarget

Research Papers:

Oncogene-mediated regulation of p53 ISGylation and functions

Yi-Fu Huang and Dmitry V. Bulavin _

PDF  |  HTML  |  Supplementary Files  |  How to cite  |  Order a Reprint

Oncotarget. 2014; 5:5808-5818. https://doi.org/10.18632/oncotarget.2199

Metrics: PDF 1536 views  |   HTML 1809 views  |   ?  


Abstract

Yi-Fu Huang1 and Dmitry V. Bulavin1,2

1 Institute of Molecular and Cell Biology, Proteos, Singapore

2 Institute for Research on Cancer and Ageing of Nice (IRCAN), INSERM, U1081-UMR CNRS 7284, University of Nice - Sophia Antipolis, Centre Antoine Lacassagne, Nice, France

Correspondence:

Dmitry V.Bulavin, email:

Keywords: p53, ISG15, cancer, protein degradation

Received: July 7, 2014 Accepted: July 10, 2014 Published: July 11, 2014

Abstract

Oncogene-mediated cellular transformation is a multistep process involving activation of growth-promoting pathways as well as inactivation of tumor suppressors. We recently found that ISGylation of the p53 tumor suppressor is an important novel mechanism to control its stability. Here we identified that Isg15-dependent regulation of p53 can be enhanced by different oncogenes. We further show that the Src-mediated phosphorylation of p53 on Tyr126 and Tyr220 has a positive effect on p53 ISGylation by enhancing Herc5 binding. In turn, deletion of Isg15 results in accumulation and activation of native p53 in transformed cells thus increasing its anti-cancer activity and suppressing tumorigenesis in mice. We propose that Isg15-dependent degradation of p53 is an alternative pathway for oncogenes to regulate p53 activity, and thus is an attractive pathway for development of new anti-cancer drugs.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.
PII: 2199